Across Europe’s tightly regulated life sciences landscape, Good Manufacturing Practices (GMP) sit at the heart of how medicines, active substances, and increasingly complex therapies are brought safely to market. 
While consumers rarely see the processes behind the products they trust, GMP functions as the silent infrastructure protecting patients from contamination, inconsistencies, and quality failures. 

And in the European Union, the gold standard for this framework is codified in the EU Guide to Good Manufacturing Practice, a document that shapes everything from facility design to data integrity discipline.

Significance of GMP

GMP refers to a set of quality assurance requirements ensuring that medicinal products are consistently produced, imported and controlled in accordance with the quality standards appropriate for their intended use. The guidelines, which underpin the day-to-day operations of Europe’s MedTech and biopharma sectors, are designed to protect patient safety by minimising risks such as contamination, mix-ups, or human error. 

Codified in EudraLex Volume 4, EU GMP requirements apply across the entire manufacturing chain. Finished medicinal products, active pharmaceutical ingredients (APIs), investigational medicines for clinical trials, and veterinary products all fall within its scope. 

For Irish manufacturers, oversight is conducted by the Health Products Regulatory Authority (HPRA), whose GMP inspections assess whether companies meet EU and national standards, in coordination with the European Medicines Agency (EMA).

Inside the core principles of GMP

While the Good Manufacturing Practice guidelines cover a plethora of requirements, the system typically revolves around these enduring principles:

1. Defined and Controlled Processes: All manufacturing processes must be clearly designed, validated and shown capable of consistently producing quality products.
2. Robust Documentation & Traceability: Instructions must be clear; records must demonstrate every required step and enable full batch history.
3. Qualified People & Suitable Facilities: Competent personnel, appropriate premises, equipment and materials are essential.
4. Effective Deviation & CAPA Management: Deviations require investigation, root cause analysis and preventive actions aligned with risk.
5. Integrated Quality Risk Management: Decisions must be science-based and proportional to risk, safeguarding patient safety.
6. Independent Quality Control Function: Testing, sampling and assessment ensure only compliant materials and products are released.
7. Batch Certification by a Qualified Person: No batch of product may be supplied until a Qualified Person certifies compliance with GMP. 

Why GMP compliance matters 

GMP is not simply a rulebook, it is a defensive architecture that shields public health. Non-compliance can lead to:

• Product recalls
• Licence suspensions
• Reputational damage
• Financial losses
• Export restrictions

For pharmaceutical manufacturing companies exporting into Europe, achieving certification aligned with the EU Good Manufacturing Practice is essential. Without it, products cannot legally enter EU markets. 

Significantly, Europe’s regulators have continuously strengthened expectations around data governance and contamination control. The revision of Annex 1 — governing sterile manufacturing — has pushed the industry towards more systematic risk-based decision-making, environmental monitoring, and contamination prevention strategies.

HPRA GMP inspection: From notification to compliance management

HPRA’s GMP inspections typically begin with formal notification, outlining the inspection scope, site details and proposed agenda, although unannounced inspections may occur where justified. 

During inspection conduct, inspectors assess the effectiveness of the manufacturer’s Pharmaceutical Quality System through document review, facility walkthroughs and interviews with key personnel, focusing on areas such as production controls, quality assurance, and deviation handling. The objective is to verify not only procedural compliance but how GMP is applied in day-to-day operations.

Following the inspection, the HPRA issues a written inspection report detailing observations, which are categorised based on their potential impact on product quality and patient safety. Manufacturers must respond with appropriate corrective and preventive actions (CAPAs) within defined timelines. 

Compliance management may include follow-up reviews, verification of CAPA effectiveness or re-inspection, ensuring deficiencies are addressed sustainably. This structured approach reinforces the expectation that GMP compliance is an ongoing regulatory responsibility rather than a one-off inspection outcome.

FAQs: Good Manufacturing Practice

What is good manufacturing practice?
Good manufacturing practice is a system of standards ensuring products are consistently made and controlled to protect consumer and patient safety.

What are the 5 principles of GMP?
Follow procedures, document work, control processes, maintain cleanliness, and ensure proper training.

Is a GMP certificate mandatory?
Yes, GMP certification is required for manufacturing medicines and other regulated products in most jurisdictions, including the EU.